Advertisement

Asymmetric lacrimal gland enlargement: an indicator for detection of pathological entities other than thyroid eye disease

  • Eri Ishikawa
  • Yasuhiro TakahashiEmail author
  • Ma. Regina Paula Valencia
  • Marian Grace Ana-Magadia
  • Hirohiko Kakizaki
Oculoplastics and Orbit

Abstract

Purpose

To examine the clinicopathological characteristics of patients with thyroid eye disease (TED) who showed asymmetric lacrimal gland enlargement.

Methods

Sixteen patients were included in this retrospective, observational case series. The following data were collected: sex, age, laterality, past medical history, laboratory results for thyroid function and other autoimmune disorders, pathological results, other systemic lesions related to lacrimal gland pathology, and the clinical course after treatment.

Results

The results of pathological examinations were consistent with non-specific dacryoadenitis in seven patients, immunoglobulin G4-related dacryoadenitis in four patients, sarcoidosis in two patients, and xanthogranuloma in one patient, respectively. The remaining two patients were proven to be extra-nodal marginal zone lymphoma of mucosa-associated lymphoid tissue type (MALT lymphoma). One patient with sarcoidosis was noted to have another related systemic lesion. After treatment or observation, the lesions were either improved or stable in almost all patients, except for the two patients with MALT lymphoma.

Conclusions

Patients with TED who present with asymmetric lacrimal gland enlargement need to be further evaluated. Biopsy of the lacrimal gland and full systemic work-up should be considered as these may lead to detection of other pathological entities, especially malignancies, which could help in saving patients’ lives.

Keywords

Thyroid eye disease Asymmetric enlargement Lacrimal gland Malignancy 

Notes

Acknowledgments

Part of this study was presented at the 41th annual meeting of the Japanese Society of Ophthalmic Surgery on January 27, 2018. The authors wish to acknowledge Dr. Makoto Ito at Department of Radiology, Aichi Medical University, for assisting the authors in the interpretation of imaging studies.

Compliance with ethical standards

Conflicts of interest

The authors have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Ethics approval and informed consent

The institutional review board (IRB) of Aichi Medical University Hospital approved this retrospective, observational study (no. 17-H053); in addition, the study was conducted in accordance with the tenets of the Declaration of Helsinki and its later amendments. The IRB granted a waiver of informed consent for this study based on the ethical guidelines for medical and health research involving human subjects established by the Japanese Ministry of Education, Culture, Sports, Science, and Technology; and by the Ministry of Health, Labour, and Welfare. The waiver was granted because the study was a retrospective chart review, not an interventional study, and because it was difficult to obtain consent from patients who had been treated several years previously. Nevertheless, at the request of the IRB, we published an outline of the study on the Aichi Medical University website that was available for public viewing; this also gave patients the opportunity to refuse to participate in the study, although none did. Personal identifiers were removed from the records prior to data analysis.

References

  1. 1.
    Wiersinga WM, Kahaly GJ (eds) (2007) Graves’ Orbitopathy: a multidisciplinary approach. Karger, Basel, pp 1–159Google Scholar
  2. 2.
    Kahaly GJ (2004) Recent developments in Graves’ ophthalmopathy imaging. J Endocrinol Investig 27:254–258CrossRefGoogle Scholar
  3. 3.
    Harris MA, Realini T, Hogg JP, Sivak-Callcott JA (2012) CT dimensions of the lacrimal gland in Graves orbitopathy. Ophthal Plast Reconstr Surg 28:69–72CrossRefGoogle Scholar
  4. 4.
    Bingham CM, Harris MA, Realini T, Nguyen J, Hogg JP, Sivak-Callcott (2014) Calculated computed tomography volumes of lacrimal glands and comparison to clinical findings in patients with thyroid eye disease. Ophthal Plast Reconstr Surg 30: 116–118Google Scholar
  5. 5.
    Huh HD, Kim JH, Kim SJ, Yoo JM, Seo SW (2016) The change of lacrimal gland volume in Korean patients with thyroid-associated ophthalmopathy. Korean J Ophthalmol 30:319–325CrossRefGoogle Scholar
  6. 6.
    Khu J, Freedman KA (2017) Lacrimal gland enlargement as an early clinical or radiological sign in thyroid orbitopathy. Am J Ophthalmol Case Rep 5:1–3CrossRefGoogle Scholar
  7. 7.
    Lee JS, Lee H, Kim JW, Chang M, Park M, Baek S (2013) Computed tomographic dimensions of the lacrimal gland in healthy orbits. J Craniofac Surg 24:712–715CrossRefGoogle Scholar
  8. 8.
    Katsura M, Mori H, Kunimatsu A, Sasaki H, Abe O, Machida T, Ohtomo K (2012) Radiological features of IgG4-related disease in the head, neck, and brain. Neuroradiology 54:873–882CrossRefGoogle Scholar
  9. 9.
    Takahashi Y, Takahashi E, Hiromatsu Y, Kakizaki H (2018) Immunoglobulin G4-positive staining of orbital lesions in thyroid eye disease: report of two cases. Mod Rheumatol 28:893–896CrossRefGoogle Scholar
  10. 10.
    Goto H, Takahira M, Azumi A, Japanese Study Group for IgG4-Related Ophthalmic Disease (2015) Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol 59:1–7CrossRefGoogle Scholar
  11. 11.
    Japan Society of Sarcoidosis and Other Granulomatous Disorders (2017) Diagnostic Standard and Guideline for Sarcoidosis - 2016. http://www.jssog.com/www/top/kenkai2016.html. Accessed 5th August 2018
  12. 12.
    Rosenbaum JT, Choi D, Wilson DJ, Grossniklaus HE, Harrington CA, Dailey RA, Ng JD, Steele EA, Czyz CN, Foster JA, Tse D, Alabiad C, Dubovy S, Parekh P, Harris GJ, Kazim M, Patel P, White V, Dolman P, Edward DP, Alkatan H, Al Hussain H, Selva D, Yeatts P, Korn B, Kikkawa D, Stauffer P, Planck SR (2015) Fibrosis, gene expression and orbital inflammatory disease. Br J Ophthalmol 99:1424–1429CrossRefGoogle Scholar
  13. 13.
    Guo J, Qian J, Zhang R (2012) Histopathology and immunohistochemical profile in idiopathic dacryoadenitis. Curr Eye Res 37:365–371CrossRefGoogle Scholar
  14. 14.
    Mombaerts I, Bilyk JR, Rose GE, AA MN, Fay A, Dolman PJ, Allen RC, Devoto MH, Harris GJ, Expert Panel of the Orbital Society (2017) Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified Delphi approach. JAMA Ophthalmol 135:769–776CrossRefGoogle Scholar
  15. 15.
    Bijlsma WR, Kalmann R (2010) Idiopathic orbital inflammation and Graves ophthalmopathy. Arch Ophthalmol 128:131–132CrossRefGoogle Scholar
  16. 16.
    Barzel US, Kolbert GS, Edberg SC, Emeson EE, Elias K (1986) Ocular sarcoidosis and Graves’ ophthalmopathy. Ann Ophthalmol 18:186–187Google Scholar
  17. 17.
    Rosenbaum JT, Choi D, Wong A, Wilson DJ, Grossniklaus HE, Harrington CA, Dailey RA, Ng JD, Steele EA, Czyz CN, Foster JA, Tse D, Alabiad C, Dubovy S, Parekh PK, Harris GJ, Kazim M, Patel PJ, White VA, Dolman PJ, Edward DP, Alkatan HM, Al Hussain H, Selva D, Yeatts RP, Korn BS, Kikkawa DO, Stauffer P, Planck SR (2015) The role of the immune response in the pathogenesis of thyroid eye disease: a reassessment. PLoS One 10:e0137654CrossRefGoogle Scholar
  18. 18.
    Eckstein AK, Lösch C, Glowacka D, Schott M, Mann K, Esser J, Morgenthaler NG (2009) Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol 93:1052–1056CrossRefGoogle Scholar
  19. 19.
    Ponto KA, Binder H, Diana T, Matheis N, Otto AF, Pitz S, Pfeiffer N, Kahaly GJ (2015) Prevalence, phenotype, and psychosocial well-being I euthyroid/hypothyroid thyroid-associated orbitopathy. Thyroid 25:942–948CrossRefGoogle Scholar
  20. 20.
    Davies MJ, Whitehead K, Quagliotto G, Wood D, Patheja RS, Sullivan TJ (2017) Adult orbital and adnexal xanthogranulomatous disease. Asia Pac J Ophthalmol (Phila) 6:435–443Google Scholar
  21. 21.
    Pemberton JD, Fay A (2012) Idiopathic sclerosing orbital inflammation: a review of demographics, clinical presentation, imaging, pathology, treatment, and outcome. Ophthal Plast Reconstr Surg 28:79–83CrossRefGoogle Scholar
  22. 22.
    Demirci H, Christianson MD (2011) Orbital and adnexal involvement in sarcoidosis: analysis of clinical features and systemic disease in 30 cases. Am J Ophthalmol 151:1074–1080CrossRefGoogle Scholar
  23. 23.
    Woolf DK, Ahmed M, Plowman PN (2012) Primary lymphoma of the ocular adnexa (orbital lymphoma) and primary intraocular lymphoma. Clin Oncol (R Coll Radiol) 24:339–344CrossRefGoogle Scholar
  24. 24.
    Dutton JJ (2010) Radiology of the orbit and visual pathways. Elsevier Saunders, PhiladelphiaGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Oculoplastic, Orbital, and Lacrimal SurgeryAichi Medical University HospitalNagakuteJapan

Personalised recommendations